{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:22:52Z","timestamp":1788348172081,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T00:00:00Z","timestamp":1787443200000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007710","name":"University of Connecticut","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["5R35GM140862"],"award-info":[{"award-number":["5R35GM140862"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.dmd.2025.100123","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T17:38:03Z","timestamp":1753724283000},"page":"100123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Visualization of CYP3A4 expression at both mRNA and protein levels simultaneously at single cell resolution in various conditions using RNAscope combined with immunofluorescence"],"prefix":"10.1016","volume":"53","author":[{"given":"Jing","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherouk M.","family":"Tawfik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Tra Giang","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beshoy","family":"Armanios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6537-5415","authenticated-orcid":false,"given":"Xiao-bo","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.dmd.2025.100123_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312808","article-title":"Cytochrome P450 enzymes and drug metabolism in humans","volume":"22","author":"Zhao","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.dmd.2025.100123_bib2","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1021\/acs.molpharmaceut.8b00787","article-title":"Intraindividual variation and correlation of cytochrome P450 activities in human liver microsomes","volume":"15","author":"Fang","year":"2018","journal-title":"Mol Pharm"},{"issue":"6","key":"10.1016\/j.dmd.2025.100123_bib3","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1124\/dmd.122.001007","article-title":"Epigenetic mechanisms contribute to intraindividual variations of drug metabolism mediated by cytochrome P450 enzymes","volume":"51","author":"Jin","year":"2023","journal-title":"Drug Metab Dispos"},{"issue":"11","key":"10.1016\/j.dmd.2025.100123_bib4","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.3390\/biomedicines10112686","article-title":"The role of CYP3A in health and disease","volume":"10","author":"Klyushova","year":"2022","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.dmd.2025.100123_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2174\/138920007779815986","article-title":"Transcriptional regulation and expression of CYP3A4 in hepatocytes","volume":"8","author":"Mart\u00ednez-Jim\u00e9nez","year":"2007","journal-title":"Curr Drug Metab"},{"issue":"2","key":"10.1016\/j.dmd.2025.100123_bib6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/clinchem\/48.2.366","article-title":"Rapid quantification of CYP3A4 expression in human leukocytes by real-time reverse transcription-PCR","volume":"48","author":"Nowakowski-Gashaw","year":"2002","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.dmd.2025.100123_bib7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1124\/mol.111.074393","article-title":"The role of CYP3A4 mRNA transcript with shortened 3\u2032-untranslated region in hepatocyte differentiation, liver development, and response to drug induction","volume":"81","author":"Li","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.dmd.2025.100123_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2021.107117","article-title":"Cytochrome P450 3A4 (CYP3A4) protein quantification using capillary western blot technology and total protein normalization","volume":"112","author":"Collins","year":"2021","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"2","key":"10.1016\/j.dmd.2025.100123_bib9","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.4081\/ejh.2016.2614","article-title":"Immunohistochemical markers of CYP3A4 and CYP3A7: a new tool towards personalized pharmacotherapy of hepatocellular carcinoma","volume":"60","author":"Fanni","year":"2016","journal-title":"Eur J Histochem"},{"key":"10.1016\/j.dmd.2025.100123_bib10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.talanta.2012.05.064","article-title":"Development and validation of an enzyme-linked immunosorbent assay for the quantification of cytochrome 3A4 in human liver microsomes","volume":"99","author":"De Bock","year":"2012","journal-title":"Talanta"},{"issue":"2","key":"10.1016\/j.dmd.2025.100123_bib11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jim.2008.09.010","article-title":"Detection of ABCC2, CYP2B6 and CYP3A4 in human peripheral blood mononuclear cells using flow cytometry","volume":"339","author":"Liptrott","year":"2008","journal-title":"J Immunol Methods"},{"issue":"2","key":"10.1016\/j.dmd.2025.100123_bib12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/dmd.121.000638","article-title":"Broad application of CYP3A4 liquid chromatography-mass spectrometry protein quantification in hepatocyte cytochrome P450 induction assays identifies nonuniformity in mRNA and protein induction responses","volume":"50","author":"Savaryn","year":"2022","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.dmd.2025.100123_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jmoldx.2011.08.002","article-title":"RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues","volume":"14","author":"Wang","year":"2012","journal-title":"J Mol Diagn"},{"issue":"1","key":"10.1016\/j.dmd.2025.100123_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40291-021-00570-2","article-title":"Evaluation of the suitability of RNAscope as a technique to measure gene expression in clinical diagnostics: a systematic review","volume":"26","author":"Atout","year":"2022","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.dmd.2025.100123_bib15","first-page":"299","article-title":"An introduction to performing immunofluorescence staining","volume":"1897","author":"Im","year":"2019"},{"key":"10.1016\/j.dmd.2025.100123_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1225847","article-title":"Combining RNAscope and immunohistochemistry to visualize inflammatory gene products in neurons and microglia","volume":"16","author":"Ball","year":"2023","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"10.1016\/j.dmd.2025.100123_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102487","article-title":"Impact on efficacy of target reduction of two FDA-approved ASO drugs by intracellular glucose levels in in vitro cell models","volume":"36","author":"Nguyen","year":"2025","journal-title":"Mol Ther Nucleic Acids"},{"issue":"2","key":"10.1016\/j.dmd.2025.100123_bib18","first-page":"28","article-title":"Identification and functional characterization of alternative transcripts of LncRNA HNF1A-AS1 and their impacts on cell growth, differentiation, liver diseases, and in response to drug induction","volume":"10","author":"Jin","year":"2024","journal-title":"Noncoding RNA"},{"issue":"4","key":"10.1016\/j.dmd.2025.100123_bib19","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1124\/mol.119.118778","article-title":"Knockdown of long noncoding RNAs hepatocyte nuclear factor 1 \u03b1 antisense RNA 1 and hepatocyte nuclear factor 4 \u03b1 antisense RNA 1 alters susceptibility of acetaminophen-induced cytotoxicity in HepaRG cells","volume":"97","author":"Chen","year":"2020","journal-title":"Mol Pharmacol"},{"issue":"6","key":"10.1016\/j.dmd.2025.100123_bib20","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1124\/dmd.109.031831","article-title":"A comparison of whole genome gene expression profiles of HepaRG cells and HepG2 cells to primary human hepatocytes and human liver tissues","volume":"38","author":"Hart","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.dmd.2025.100123_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10565-011-9208-4","article-title":"Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins","volume":"28","author":"Gerets","year":"2012","journal-title":"Cell Biol Toxicol"},{"issue":"2","key":"10.1016\/j.dmd.2025.100123_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229106","article-title":"A comparison of hepato-cellular in vitro platforms to study CYP3A4 induction","volume":"15","author":"Bulutoglu","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.dmd.2025.100123_bib23","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/hep.24132","article-title":"HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity","volume":"53","author":"McGill","year":"2011","journal-title":"Hepatology"},{"issue":"33","key":"10.1016\/j.dmd.2025.100123_bib24","doi-asserted-by":"crossref","first-page":"53899","DOI":"10.18632\/oncotarget.19108","article-title":"Development of hepatoma-derived, bidirectional oval-like cells as a model to study host interactions with hepatitis C virus during differentiation","volume":"8","author":"Ito","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.dmd.2025.100123_bib25","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1242\/jcs.043034","article-title":"Nucleocytoplasmic shuttling of soluble tubulin in mammalian cells","volume":"122","author":"Akoumianaki","year":"2009","journal-title":"J Cell Sci"},{"issue":"1","key":"10.1016\/j.dmd.2025.100123_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92011-7","article-title":"A versatile microfluidic tool for the 3D culture of HepaRG cells seeded at various stages of differentiation","volume":"11","author":"Boul","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.dmd.2025.100123_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.mex.2020.100853","article-title":"Evaluating the effect of type 2 diabetes mellitus on CYP450 enzymes and P-gp activities, before and after glycemic control: a protocol for a case\u2013control pharmacokinetic study","volume":"7","author":"Neyshaburinezhad","year":"2020","journal-title":"MethodsX"},{"issue":"12","key":"10.1016\/j.dmd.2025.100123_bib28","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/17425255.2023.2288246","article-title":"What is the impact of type 2 diabetes mellitus on CYP450 metabolic activities?","volume":"19","author":"Tomlinson","year":"2023","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"11","key":"10.1016\/j.dmd.2025.100123_bib29","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1111\/cts.13394","article-title":"Impact of type 2 diabetes on in vivo activities and protein expressions of cytochrome P450 in patients with obesity","volume":"15","author":"Kvitne","year":"2022","journal-title":"Clin Transl Sci"},{"issue":"1","key":"10.1016\/j.dmd.2025.100123_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/srep28178","article-title":"Long-term exposure to abnormal glucose levels alters drug metabolism pathways and insulin sensitivity in primary human hepatocytes","volume":"6","author":"Davidson","year":"2016","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.dmd.2025.100123_bib31","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1124\/dmd.120.000195","article-title":"Histone methyltransferase G9a regulates expression of nuclear receptors and cytochrome P450 enzymes in HepaRG cells at basal level and in fatty acid induced steatosis","volume":"48","author":"Pande","year":"2020","journal-title":"Drug Metab Dispos"},{"issue":"11","key":"10.1016\/j.dmd.2025.100123_bib32","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1124\/dmd.124.001873","article-title":"Correlations of long noncoding RNA HNF4A-AS1 alternative transcripts with liver diseases and drug metabolism","volume":"52","author":"Jin","year":"2024","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.dmd.2025.100123_bib33","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1124\/mol.118.112235","article-title":"A transcriptional regulatory network containing nuclear receptors and long noncoding RNAs controls basal and drug-induced expression of cytochrome P450s in HepaRG cells","volume":"94","author":"Chen","year":"2018","journal-title":"Mol Pharmacol"},{"issue":"5","key":"10.1016\/j.dmd.2025.100123_bib34","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1124\/dmd.119.089557","article-title":"Acetaminophen-induced liver injury alters expression and activities of cytochrome P450 enzymes in an age-dependent manner in mouse liver","volume":"48","author":"Bao","year":"2020","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"10.1016\/j.dmd.2025.100123_bib35","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1124\/dmd.121.000459","article-title":"Alterations of cytochrome P450-mediated drug metabolism during liver repair and regeneration after acetaminophen-induced liver injury in mice","volume":"50","author":"Bao","year":"2022","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.dmd.2025.100123_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-18174-z","article-title":"A novel differentiated HuH-7 cell model to examine bile acid metabolism, transport and cholestatic hepatotoxicity","volume":"12","author":"Saran","year":"2022","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.dmd.2025.100123_bib37","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/cpt.2887","article-title":"3D spheroid primary human hepatocytes for prediction of cytochrome P450 and drug transporter induction","volume":"113","author":"J\u00e4rvinen","year":"2023","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.dmd.2025.100123_bib38","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.124.001497","article-title":"Utilization of a human liver tissue chip for drug-metabolizing enzyme induction studies of perpetrator and victim drugs","volume":"53","author":"Ohri","year":"2025","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"10.1016\/j.dmd.2025.100123_bib39","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41592-023-01829-8","article-title":"Spatiotemporally resolved transcriptomics reveals the subcellular RNA kinetic landscape","volume":"20","author":"Ren","year":"2023","journal-title":"Nat Methods"},{"key":"10.1016\/j.dmd.2025.100123_bib40","article-title":"Single-cell metabolic profiling reveals subgroups of primary human hepatocytes showing heterogeneous responses to drug challenge","author":"Sanchez-Quant","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.dmd.2025.100123_bib41","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fcell.2018.00044","article-title":"Microenvironmental signals and biochemical information processing: cooperative determinants of intratumoral plasticity and heterogeneity","volume":"6","author":"Davies","year":"2018","journal-title":"Front Cell Dev Biol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625091329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625091329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:55:38Z","timestamp":1772808938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955625091329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0090955625091329"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100123","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Visualization of CYP3A4 expression at both mRNA and protein levels simultaneously at single cell resolution in various conditions using RNAscope combined with immunofluorescence","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100123","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100123"}}